We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BASF Enhances Commitment to Copper Hydrometallurgy Business
Read MoreHide Full Article
BASF SE (BASFY - Free Report) announced a strategic shift in its copper hydrometallurgy business by intensifying the efforts to develop the next generation of leaching aids with enhanced efficiency. Additionally, the LixTRA product line will also be further advanced to drive innovative solutions. The shift is in response to the ever-increasing demand for copper and the industry’s need for sustainable and resource-efficient processing.
To enable this shift, BASF will be relocating its Global R&D leaching activities from Tucson, AZ, to its state-of-the-art R&D facility in Houston, TX, thereby consolidating expertise under one roof. BASF is also decentralizing its technical and analytical capabilities for solvent extraction and electrowinning, which will ensure support to all customers using LIX and LixMS. Users will also benefit from enhanced technical services and analytical support tailored to their needs.
Continued efforts to innovate in the field of sulfidic and non-sulfidic flotation remain a focus. Also, a strong commitment to developing cutting-edge formulations, marketed under the renowned brands Lupromin, Luprofroth, and Luproset, will significantly improve the efficiency and effectiveness of mineral processing. BASFY, through these adjustments, will be better placed to cater to the needs and challenges of the mining industry with chemical innovation.
BASFY stock has lost 3.9% over the past year compared with the industry’s 25.6% decline.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have gained 30.6% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. BCPC’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. BCPC’s shares have gained 10% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
BASF Enhances Commitment to Copper Hydrometallurgy Business
BASF SE (BASFY - Free Report) announced a strategic shift in its copper hydrometallurgy business by intensifying the efforts to develop the next generation of leaching aids with enhanced efficiency. Additionally, the LixTRA product line will also be further advanced to drive innovative solutions. The shift is in response to the ever-increasing demand for copper and the industry’s need for sustainable and resource-efficient processing.
To enable this shift, BASF will be relocating its Global R&D leaching activities from Tucson, AZ, to its state-of-the-art R&D facility in Houston, TX, thereby consolidating expertise under one roof. BASF is also decentralizing its technical and analytical capabilities for solvent extraction and electrowinning, which will ensure support to all customers using LIX and LixMS. Users will also benefit from enhanced technical services and analytical support tailored to their needs.
Continued efforts to innovate in the field of sulfidic and non-sulfidic flotation remain a focus. Also, a strong commitment to developing cutting-edge formulations, marketed under the renowned brands Lupromin, Luprofroth, and Luproset, will significantly improve the efficiency and effectiveness of mineral processing. BASFY, through these adjustments, will be better placed to cater to the needs and challenges of the mining industry with chemical innovation.
BASFY stock has lost 3.9% over the past year compared with the industry’s 25.6% decline.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. (AKZOY - Free Report) , Newmont Corporation (NEM - Free Report) and Balchem Corporation (BCPC - Free Report) . While AKZOY and NEM currently sport a Zacks Rank #1 (Strong Buy) each, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have gained 30.6% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. BCPC’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. BCPC’s shares have gained 10% in the past year.